Literature DB >> 4858717

Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture.

M E Jobin, J L Fahey, Z Price.   

Abstract

Cell line LA-49, derived from pleural fluid cells of a patient with IgD multiple myeloma, was established in culture and maintained for more than 1 yr. The D-myeloma protein produced in culture was similar to the serum D-myeloma protein in electrophoretic mobility and in delta- and lambda-chain antigens. The plasma cell tumor culture, LA-49, differed from numerous immunoglobulin-producing B-lymphoblastoid cell lines established in this laboratory in: (a) Morphology (revealing various stages of maturation); (b) type of immunoglobulin produced (IgD vs. IgM, IgG, and/or, rarely, IgA); (c) growth characteristics (requirement of plasmacyte-stimulating factor); and (d) chromosomal features (polyploid vs. pseudodiploid). A growth factor was needed for cell division and maintenance of culture viability. This factor was supplied readily by irradiated feeder layers of normal human fibroblasts or conditional media from fibroblast cultures. Preliminary characterization of this factor revealed it to be a protein with a mol wt of approximately 150,000 daltons.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4858717      PMCID: PMC2139596          DOI: 10.1084/jem.140.2.494

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  ELECTRON MICROSCOPIC OBSERVATIONS OF BONE MARROW FROM PATIENTS WITH MULTIPLE MYELOMA.

Authors:  G D SORENSON
Journal:  Lab Invest       Date:  1964-03       Impact factor: 5.662

2.  On the role of tanning in the pathogenesis of abnormal protein deposits: ceruloplasmin and catechol amines as a potential tanning system.

Authors:  E P BENDITT
Journal:  Lab Invest       Date:  1961 Nov-Dec       Impact factor: 5.662

3.  Lymphocyte culture in agar.

Authors:  A S Coulson; A Turk; P R Glade; L N Chessin
Journal:  Lancet       Date:  1968-01-13       Impact factor: 79.321

4.  Immunoglobulin synthesis by cultured mouse myeloma cells.

Authors:  Y Namba; M Hanaoka
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

5.  Identification of the colony-stimulating cell in human peripheral blood.

Authors:  D W Golde; M J Cline
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

6.  Electron microscopic study of human leukemic cells in tissue culture.

Authors:  E De Harven; B Clarkson; A Strife
Journal:  Cancer       Date:  1967-06       Impact factor: 6.860

7.  Ultrastructure of normal and leukemic leukocytes in human peripheral blood.

Authors:  D R Anderson
Journal:  J Ultrastruct Res       Date:  1966-09

8.  A three-dimensional model of membrane ruffling from transmission and scanning electron microscopy of cultured monkey kidney cells (LLCMK 2 ).

Authors:  Z H Price
Journal:  J Microsc       Date:  1972-06       Impact factor: 1.758

9.  ACTION OF RADIATION ON MAMMALIAN CELLS III. RELATIONSHIP BETWEEN REPRODUCTIVE DEATH AND INDUCTION OF CHROMOSOME ANOMALIES BY X-IRRADIATION OF EUPLOID HUMAN CELLS IN VITRO.

Authors:  T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1958-08-15       Impact factor: 11.205

10.  Differentiation of mouse plasmocytomas in vitro: two phenotypically stabilized variants of the same cell.

Authors:  A Paraf; M A Moyne; J F Duplan; R Scherrer; M Stanislawski; M Bettane; L Lelievre; P Rouze; J M Dubert
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

View more
  9 in total

1.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes.

Authors:  R C Seeger; R A Robins; R H Stevens; R B Klein; D J Waldman; P M Zeltzer; S W Kessler
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

Review 3.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 4.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

5.  In vitro culture of primary plasmacytomas requires stromal cell feeder layers.

Authors:  A Degrassi; D M Hilbert; S Rudikoff; A O Anderson; M Potter; H G Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2.

Authors:  N Jackson; J Lowe; J Ball; E Bromidge; N R Ling; S Larkins; M J Griffith; I M Franklin
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 7.  Human monoclonal antibodies: methods of production and some aspects of their application in oncology.

Authors:  L Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

Authors:  S Shimizu; R Yoshioka; Y Hirose; S Sugai; J Tachibana; S Konda
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Cancer associated fibroblasts and tumor growth: focus on multiple myeloma.

Authors:  Kim De Veirman; Luigia Rao; Elke De Bruyne; Eline Menu; Els Van Valckenborgh; Ivan Van Riet; Maria Antonia Frassanito; Lucia Di Marzo; Angelo Vacca; Karin Vanderkerken
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.